Results 241 to 250 of about 1,021,856 (349)

The Time of TNFα, INFγ, TGFβ2 in Patients with Ischemic Heart Disease (IHD) Prior and Following the Coronary Bypass Graft Surgery (CABG)

, 2018
E. I. Markelova, А. А. Зенина, О С Сидорова   +2 more
openalex   +1 more source

A systematic review of medication adherence and mortality in chronic disease: Implications for clinical guidelines and policy

British Journal of Clinical Pharmacology, EarlyView.
Objectives This systematic review aims to investigate whether good medication adherence in adults with chronic conditions is associated with a lower mortality risk compared to poor adherence within published literature, and the extent to which this relationship is represented within South African policy and legislation.
Jessica Hamuy Blanco, Dina C. Janse van Rensburg, Audrey Jansen van Rensburg, Corrie Uys, Natalie Schellack   +4 more
wiley   +1 more source

Key genes of Taohong Siwu decoction in treating coronary heart disease based on network pharmacology and Mendelian randomization. [PDF]

Medicine (Baltimore)
Wang C, Li X, Wang J.
europepmc   +1 more source

Machine learning methods for predicting adverse drug events: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Predicting adverse drug events (ADEs) in outpatient settings is crucial for improving medication safety, identifying high‐risk patients and reducing health‐care costs. While traditional methods struggle with the complexity of health‐care data, machine learning (ML) models offer improved prediction capabilities; however, their effectiveness in ...
Niaz Chalabianloo, Fatemeh Ahmadi, Mohammad Ali Omrani, Sheikh S. Abdullah, Neda Rostamzadeh, Atefeh Jafari, Lujain Izzedin, Kamran Sedig, Flory T. Muanda   +8 more
wiley   +1 more source

Causal effects between gut microbiota and coronary heart disease: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Chen H, Zhang C, Yao G, Zou X, Pan G.
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

SECTM1 Regulates Monocyte Levels and Is Associated With Incident Coronary Heart Disease. [PDF]

JACC Basic Transl Sci
Tahir UA, Cruz D, Shen D, Tiwari G, Liu J, Huber M, Chan C, Deng S, Benson MD, Robbins J, Chen ZZ, Farrell L, Ekunwe L, Hall M, Psaty BM, Floyd JS, Asnani A, Swirski FK, Wilson JG, Gerszten RE.   +19 more
europepmc   +1 more source

Gerontological features of the effect of the new coronavirus infection on the interleukin profile, inflammation and endogenous intoxication in mature and elderly patients with coronary heart disease

A. V. Chernov, Guzyal Sh. Safuanova, Vladimir N. Potapov, О. Т. Богова, Maria A. Shurgaya, С. А. Чепурненко, Yuri E. Antonenkov, Г. В. Шавкута, Vladislav Belov, Nadezhda Alexandrovna Shchetinina, Олег Валериевич Судаков, В. И. Никуличева, Т Е Липатова, Е. Л. Борщук   +13 more
openalex   +2 more sources

Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Our international cohort study assessed the comparative effectiveness and safety of direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) among patients with non‐valvular atrial fibrillation (NVAF) using antiarrhythmic drugs. Methods Using the United Kingdom's (UK's) Clinical Practice Research Datalink Aurum and Québec claims data, we
Fabian Maximilian Meinert, Jenny Dimakos, Ying Cui, Kristian B. Filion, Christel Renoux, Antonios Douros   +5 more
wiley   +1 more source

Analysis of risk factors for in-stent restenosis in patients with coronary heart disease after PCI. [PDF]

Medicine (Baltimore)
Tang D, Liu C.
europepmc   +1 more source